On September 9, 2026, Fortrea Holdings Inc. reinstated Jason Knoblauch as Chief Financial Officer and principal financial officer following a settlement agreement that resolved litigation with his prior employer regarding alleged restrictive covenant violations. David Smith stepped down from the Interim CFO role but remains on the Board of Directors. Mr. Knoblauch retains his previously disclosed compensation package. The company operates in the clinical research organization industry, providing outsourced drug development services.
